Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

224735

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Cumbria
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what funding (a) in total and (b) per capita has been allocated for Cumbria Clinical Commissioning Group for each year from 2013-14 to 2019-20.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	226114
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>Clinical commissioning group (CCG) funding has not been decided beyond 2015/16. Notified revenue allocations and per capita allocations for Cumbria CCG are:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Allocation £000</p></td><td><p>Per capita £</p></td></tr><tr><td><p>2013/14</p></td><td><p><del class="ministerial">692,122</del></p><p><ins class="ministerial">663,133</ins></p></td><td><p><del class="ministerial">1,330</del></p><p><ins class="ministerial">1,274</ins></p></td></tr><tr><td><p>2014/15</p></td><td><p>677,324</p></td><td><p>1,299</p></td></tr><tr><td><p>2015/16</p></td><td><p>685,654</p></td><td><p>1,313</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>These figures exclude running cost and Better Care Fund allocations.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/03/2015 14:39:07 question first ministerially corrected 19/03/2015 18:02:16 answering member 4020 label Biography information for George Freeman previous answer version 48371 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1503 label Biography information for Mr Jamie Reed

431742

	registered interest
	date	23/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Per Capita Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much NHS England spent per head on mental health in each year since 2008.
	tabling member constituency	Central Suffolk and North Ipswich
	tabling member printed	Dr Poulter
	uin	17404
	answer	answer is ministerial correction date of answer 26/11/2015 answer text <p>NHS England was formed in April 2013.</p><br /><p>The table below shows actual expenditure by clinical commissioning groups (CCGs) on mental health in 2013/14 and 2014/15 and forecast spend in 2015/16. This does not include spending on mental health services directly commissioned by NHS England.</p><p>Total actual expenditure by on mental health by CCGs across all providers for 2013/14 and 2014/15 and the total forecast expenditure for 2015/16</p><br /><table><tbody><tr><td><p>2013/14 actual spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td><td><p>2014/15 actual spend (£ <ins class="ministerial">billion</ins><del class="ministerial">million</del>)</p></td><td><p>2015/16 forecast spend (£ <ins class="ministerial">billion </ins><del class="ministerial">million</del>)</p></td></tr><tr><td><p>9.6</p></td><td><p>10.1</p></td><td><p>10.6</p></td></tr></tbody></table><br /><p><em>Source:</em> NHS England</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 26/11/2015 16:25:03 question first ministerially corrected 02/12/2015 14:16:07 answering member 4020 label Biography information for George Freeman previous answer version 32352 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	3932 label Biography information for Dr Dan Poulter

522126

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the Medicines and Healthcare Products Regulatory Agency holds any clinical trial data for HPV vaccines which is not in the public domain.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	38833
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>There are <del class="ministerial">two</del> <ins class="ministerial">three </ins>human papilloma virus vaccines licensed in the European Union: Cervarix<ins class="ministerial">,</ins> <del class="ministerial">and</del> <ins class="ministerial">Gardasil and </ins>Gardasil 9. These products are licensed centrally throughout Europe by the European Commission via the European Medicines Agency (EMA). Applicants for centrally authorised products are required to submit all relevant supporting clinical trials data, whether published or not, to the EMA directly and not to the Medicines and Healthcare products Regulatory Agency.</p><p> </p><p>Under current medicines legislation, the EMA database registers all EU-approved clinical trials of investigational medicinal products. Since March 2011 this information has been publicly accessible through the EU Clinical Trials Register (except adult Phase 1 trials). The EU Clinical Trials Register includes all EU-conducted trials since May 2004 when the Clinical Trials Directive was implemented and can be found here:</p><p> </p><p><a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">https://www.clinicaltrialsregister.eu/ctr-search/search</a></p><p> </p><p>Furthermore since July 2014 clinical trial sponsors have been required to provide a summary of their trial results uploaded onto the EU Clinical Trials Register within one year of their trial completing. There is a two year programme of back-loading underway to provide summaries of trial results for all trials on the Register back to when the EudraCT database was initiated in May 2004.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/06/2016 10:57:37 question first ministerially corrected 13/06/2016 10:14:27 answering member 4020 label Biography information for George Freeman previous answer version 2228 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	1506 label Biography information for Andrew Gwynne

1146644

	registered interest
	date	26/09/2019
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Roads: Suffolk
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what discussions his Department has had with Suffolk county council on the Ipswich northern route since 1 January 2019.
	tabling member constituency	Ipswich
	tabling member printed	Sandy Martin
	uin	291481
	answer	answer is ministerial correction date of answer 01/10/2019 answer text <p><del class="ministerial">Since 1 January 2019, the Department has liaised with Suffolk County Council to support them in developing the evidence required to facilitate a thorough and efficient assessment of the proposed scheme. This has included analytical support to scheme promoters, in advance of Transport East submitting the scheme proposal to the Department on the County Council’s behalf in July 2019, and following this submission.</del></p><p><ins class="ministerial">Department for Transport officials have had regular discussions with Suffolk County Council regarding the Ipswich Northern Route since January 1 2019. As well as regular engagement, the Department has offered analytical support to all scheme promoters as part of the Major Road Network (MRN) and Large Local Majors (LLM) programme.</ins></p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/10/2019 16:04:51 question first ministerially corrected 08/10/2019 13:22:47 answering member 4020 label Biography information for George Freeman previous answer version 136591 answering member constituency Mid Norfolk answering member printed George Freeman answering member 4020 label Biography information for George Freeman
	tabling member	4678 label Biography information for Sandy Martin

224731

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: South Yorkshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which schemes in Sheffield and South Yorkshire will be (a) cancelled, (b) delayed or (c) deferred as a result of the transfer of £197 million from the NHS Technology Fund budget for 2014-15 to the revenue budget.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	225998
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>The Department has not cancelled, delayed or deferred any agreed funding for specific capital schemes in National Health Service trusts or foundation trusts.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 225995 question first answered 06/03/2015 14:49:13 answering member 4020 label Biography information for George Freeman
	tabling member	394 label Biography information for Mr Clive Betts

224732

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: South Yorkshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which schemes in Sheffield and South Yorkshire will be (a) cancelled, (b) delayed or (c) deferred as a result of the transfer of £650 million from the NHS capital budget for 2014-15 to the revenue budget.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	225995
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>The Department has not cancelled, delayed or deferred any agreed funding for specific capital schemes in National Health Service trusts or foundation trusts.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 225998 question first answered 06/03/2015 14:49:13 answering member 4020 label Biography information for George Freeman
	tabling member	394 label Biography information for Mr Clive Betts

224734

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Greater Manchester
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect of devolution of spending to Greater Manchester on (a) patients who live outside the Greater Manchester area but who are registered with a GP there and (b) patients who wish to receive treatment at a hospital in Greater Manchester but who live outside the area.
	tabling member constituency	Warrington North
	tabling member printed	Helen Jones
	uin	226124
	answer	answer is ministerial correction date of answer 06/03/2015 answer text <p>This is a historic partnership between local organisations in Greater Manchester (GM), with general practitioners as clinical leaders working with elected leaders to improve services for people living in the area.</p><p> </p><p> </p><p> </p><p>The National Health Service bodies involved, including NHS England and the relevant clinical commissioning groups, will remain statutorily accountable for the exercise of their functions. GM will work collaboratively with local non-GM bodies and take into account the impact of GM decisions upon non-GM bodies and their communities.</p><p> </p><p> </p><p> </p><p>The fundamental national policies including Choice, inspection regimes, guidance and regulations will continue to apply to GM but, in line with the Five Year Forward View published by NHS England, GM will exercise greater freedom in how they are implemented so that local services better reflect the priorities of local patients and service users.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/03/2015 14:37:14 answering member 4020 label Biography information for George Freeman
	tabling member	432 label Biography information for Helen Jones

224729

	registered interest
	date	03/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Brain: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will fund research on using a skin test to detect hard-to-spot brain diseases.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	226008
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Department's National Institute for Health Research welcomes funding applications for research into any aspect of human health, including tests for biological markers of brain diseases. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/03/2015 12:44:58 answering member 4020 label Biography information for George Freeman
	tabling member	1597 label Biography information for David Simpson

225190

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 25 February 2014, Official Report, column 279W and 28 February 2014, Official Report, column 583W, on NHS: innovation, for what reason NHS England has not published the minutes of the meetings referred to in the Answers; and if he will direct NHS England to publish those minutes.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	226401
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The remit of patient and public engagement now falls to NHS England’s new Patient and Public Voice Assurance Group which met for the first time in June 2014.</p><p> </p><p> </p><p> </p><p>Discussions about the publication of the minutes of the Patient and Public Voice Assurance Group are ongoing.</p><p> </p><p> </p><p> </p><p>The Patient and Public Engagement Steering Group is no longer in existence and NHS England has no plans to publish the minutes of the Patient and Public Engagement Steering Group.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/03/2015 16:12:42 answering member 4020 label Biography information for George Freeman
	tabling member	4089 label Biography information for Tessa Munt

225200

	registered interest
	date	04/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cervical Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to improve cervical screening rates.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	226258
	answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>A leaflet sent out with every invitation for cervical screening provides women with clear, honest and balanced information about the benefits and limitations of cervical screening in order to ensure women are able to make an informed decision as to whether to have a cervical screening test or not.</p><p> </p><p> </p><p> </p><p><em>Improving Outcomes: A Strategy for Cancer</em> (January 2011) makes clear the important role that cervical screening plays in preventing cervical cancer. The strategy also notes that some groups and communities are not accessing cancer screening services. Public Health England (PHE) is working with NHS England via the Public Health Section 7A agreement to develop a system of performance improvement through the use of performance floors, and strengthened governance for screening. The aims of the performance floors are:</p><p> </p><p> </p><p> </p><p>- Improving performance and equity of service over time by reducing the range of variation at a local level.</p><p> </p><p>- Enabling easy identification of poor performance and the setting of objectives and plans for local action, to reduce variation and improve performance.</p><p> </p><p> </p><p> </p><p>PHE will look at research provided by the STRATEGIC study (Strategies to increase cervical screening uptake at first invitation) to identify methods to help increase uptake among women. The STRATEGIC study will be publishing findings in May 2016, more details of this can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nets.nihr.ac.uk/projects/hta/0916401" target="_blank">http://www.nets.nihr.ac.uk/projects/hta/0916401</a></p><p> </p><p> </p><p> </p><p>The cervical cancer screening programme was established on the basis that it would prevent, and lead to the early diagnosis of, cervical cancer reducing the number of premature deaths.<sup><sup>[1]</sup></sup></p><p> </p><p> </p><p> </p><p>No assessment has been made of the financial consequence to the NHS on the low uptake of cervical screening. However, cost-effectiveness is a key criteria of the UK National Screening Committee recommending whether or not screening for a particular condition should take place. For example, a cost-effectiveness evaluation of the current pilot of human papillomavirus (HPV) testing as primary cervical screening is being undertaken alongside the clinical evaluation of the pilot. Cancer Research UK has estimated that, when fully implemented, HPV testing as primary screening could prevent an additional 600 cancers a year.<sup><sup>[2]</sup></sup></p><p> </p><br /><p>[1] Peto et al, The cervical cancer epidemic that screening has prevented in the UK, Lancet 2004; 364: 249-56</p><p>[2] <a href="http://msc.sagepub.com/content/early/2013/06/10/0969141313492313" target="_blank">http://msc.sagepub.com/content/early/2013/06/10/0969141313492313</a></p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 226261 226264 question first answered 09/03/2015 17:47:03 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi